{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:05Z","timestamp":1792786145306,"version":"4.5.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"\u00e2\u20ac\u0153Yiqi\u00e2\u20ac\u009d project","award":["2025YQFH04"],"award-info":[{"award-number":["2025YQFH04"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:p>\n                    Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants, but evidence linking PFAS exposure to hypertension remains limited and inconsistent. We analyzed 5 contiguous National Health and Nutrition Examination Survey cycles (2005\u20132014), including 6644 adults. Associations with hypertension were estimated by multivariable logistic regression. Restricted cubic splines and piecewise threshold models assessed nonlinearity. Mixture effects were examined using weighted quantile sum and quantile g-computation (Q-gcomp). Eight machine-learning classifiers were compared using cross-validated AUC. XGBoost was selected as the final model and interpreted with SHAP. In continuous multivariable models, PFOA (OR, 1.04, 95% CI, 1.00\u20131.08,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.036) and PFOS (OR, 1.04, 95% CI, 1.01\u20131.07,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.007) were positively associated with hypertension; Me-PFOSA-AcOH showed a marginal positive association (OR, 1.07, 95% CI, 1.00\u20131.14,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.045). Quartile analyses showed elevated odds for PFOA and for PFOS. Spline and threshold models identified compound-specific inflection points with differential associations below versus above cutpoints. Weighted quantile sum positive-direction index was modestly associated with hypertension (OR, 1.13, 95% CI, 1.03\u20131.26,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.01) with PFUA contributing most; q-gcomp results were concordant. XGBoost achieved the highest discrimination (AUC\u2005=\u20050.814); SHAP ranked PFOS, PFNA and PFOA as leading predictors by mean SHAP. Specific PFAS were associated with prevalent hypertension, and PFAS mixtures showed a modest joint effect. Machine-learning and SHAP analysis highlighted specific congeners driving predictive signal.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048599","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:01:10Z","timestamp":1778745670000},"page":"e48599","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["PFAS exposure and hypertension in US adults: A multi-method, cross-sectional analysis of NHANES 2005 to 2014"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4709-0880","authenticated-orcid":false,"given":"Wenwen","family":"Xiao","sequence":"first","affiliation":[{"name":"Eastern Theater Command Centers for Disease Control and Prevention, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ma","sequence":"additional","affiliation":[{"name":"Eastern Theater Command Centers for Disease Control and Prevention, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojin","family":"Jian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, PLA Joint Logistic Support Force 902 Hospital, Bengbu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Eastern Theater Command Centers for Disease Control and Prevention, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daolin","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Xuyi People\u2019s Hospital, Kangda College of Nanjing Medical University, Xuyi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Cao","sequence":"additional","affiliation":[{"name":"Eastern Theater Command Centers for Disease Control and Prevention, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension.","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-025-00728-8","article-title":"Global, regional, and national burden of heart failure and its underlying causes, 1990-2021: results from the global burden of disease study 2021.","volume":"13","author":"Ran","year":"2025","journal-title":"Biomark Res"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"2472039","DOI":"10.1080\/0886022X.2025.2472039","article-title":"Global, regional, and national burden of cardiovascular disease attributable to kidney dysfunction (1990-2021) with projections to 2050: analysis of the 2021 Global Burden of Disease study.","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren Fail"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCRESAHA.120.318729","article-title":"Hypertension in low- and middle-income countries.","volume":"128","author":"Schutte","year":"2021","journal-title":"Circ Res"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1186\/s12889-025-23389-6","article-title":"Trends analysis of the global burden of hypertensive heart disease from 1990 to 2021: a population-based study.","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Public Health"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.5646\/ch.2025.31.e36","article-title":"Global, regional, and national burden of hypertensive heart disease in 1990-2021, with forecasts to 2050: a Global Burden of Disease Study 2021.","volume":"31","author":"Lee","year":"2025","journal-title":"Clin Hypertens"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41545-023-00274-6","article-title":"Revisiting the \u201cforever chemicals,\u201d PFOA and PFOS exposure in drinking water.","volume":"6","author":"Wee","year":"2023","journal-title":"NPJ Clean Water"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1021\/acs.est.3c03702","article-title":"Per- and polyfluoroalkyl substances in food packaging: migration, toxicity, and management strategies.","volume":"58","author":"Phelps","year":"2024","journal-title":"Environ Sci Technol"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"eabg9065","DOI":"10.1126\/science.abg9065","article-title":"Per- and polyfluoroalkyl substances in the environment.","volume":"375","author":"Evich","year":"2022","journal-title":"Science"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12940-020-00656-0","article-title":"Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults.","volume":"19","author":"Pitter","year":"2020","journal-title":"Environ Health"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"1173101","DOI":"10.3389\/fpubh.2023.1173101","article-title":"Association between per- and polyfluoroalkyl substances and risk of hypertension: a systematic review and meta-analysis.","volume":"11","author":"Xiao","year":"2023","journal-title":"Front Public Health"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1536\/ihj.23-036","article-title":"The association of hypertension with perfluoroalkyl and polyfluoroalkyl substances.","volume":"64","author":"Yang","year":"2023","journal-title":"Int Heart J"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"116362","DOI":"10.1016\/j.envres.2023.116362","article-title":"The relationship between perfluoroalkyl substances and hypertension: a systematic review and meta-analysis.","volume":"232","author":"Pan","year":"2023","journal-title":"Environ Res"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"114158","DOI":"10.1016\/j.ijheh.2023.114158","article-title":"Associations of per- and polyfluoroalkyl substances and alternatives with reproductive hormones in women of childbearing age.","volume":"250","author":"Lin","year":"2023","journal-title":"Int J Hyg Environ Health"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"105573","DOI":"10.1016\/j.envint.2020.105573","article-title":"Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.","volume":"137","author":"Lin","year":"2020","journal-title":"Environ Int"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/HYPERTENSIONAHA.121.18809","article-title":"Per- and polyfluoroalkyl substances and incident hypertension in multi-racial\/ethnic women: the study of women\u2019s health across the nation.","volume":"79","author":"Ding","year":"2022","journal-title":"Hypertension"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"109930","DOI":"10.1016\/j.envint.2025.109930","article-title":"Differential impact of per- and polyfluoroalkyl substances exposure on hypertension risk by kidney function and metabolic status.","volume":"206","author":"Kim","year":"2025","journal-title":"Environ Int"},{"key":"R18-20260805","article-title":"Association of PFDeA exposure with hypertension (NHANES, 2013\u20132018).","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1370971","DOI":"10.3389\/fpubh.2024.1370971","article-title":"Association of exposure to multiple perfluoroalkyl and polyfluoroalkyl substances and glucose metabolism in National Health and Nutrition Examination Survey 2017-2018.","volume":"12","author":"Tian","year":"2024","journal-title":"Front Public Health"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"110589","DOI":"10.1016\/j.ecoenv.2020.110589","article-title":"Association between perfluoroalkyl acids and the prevalence of hypertension among US adults.","volume":"196","author":"Liao","year":"2020","journal-title":"Ecotoxicol Environ Saf"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/HYPERTENSIONAHA.123.22127","article-title":"Positive associations of perfluoroalkyl and polyfluoroalkyl substances with hypertension may be attenuated by endogenous sex hormones: a nationally representative cross-sectional study.","volume":"81","author":"Wu","year":"2024","journal-title":"Hypertension"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"e71014","DOI":"10.1002\/brb3.71014","article-title":"Exploring the association between per- and polyfluoroalkyl substances exposure and the risk of stroke: a systematic investigation using NHANES data analysis, network toxicology and molecular docking approaches.","volume":"15","author":"Jiang","year":"2025","journal-title":"Brain Behav"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"1487956","DOI":"10.3389\/fcvm.2024.1487956","article-title":"Exposure to specific polyfluoroalkyl chemicals is associated with cardiovascular disease in US adults: a population-based study.","volume":"11","author":"Xiao","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"12421","DOI":"10.3390\/ijerph191912421","article-title":"Associations between mixture of perfluoroalkyl substances and lipid profile in a highly exposed adult community in the veneto region.","volume":"19","author":"Batzella","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"100210","DOI":"10.1016\/j.eehl.2025.100210","article-title":"Serum perfluoroalkyl and polyfluoroalkyl substances and the risk of cardiometabolic diseases: unraveling the mediating role of inflammatory markers.","volume":"5","author":"Zhao","year":"2026","journal-title":"Eco-Environ Health"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"1418134","DOI":"10.3389\/fpubh.2024.1418134","article-title":"Exposure to per- and polyfluoroalkyl substances is associated with impaired cardiovascular health: a cross-sectional study.","volume":"12","author":"Zong","year":"2024","journal-title":"Front Public Health"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"123615","DOI":"10.1016\/j.envpol.2024.123615","article-title":"Exposure to per- and polyfluoroalkyl substance and metabolic syndrome: a nationally representative cross-sectional study from NHANES, 2003-2018.","volume":"346","author":"Wu","year":"2024","journal-title":"Environ Pollut"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"112565","DOI":"10.1016\/j.envres.2021.112565","article-title":"How to investigate human health effects related to exposure to mixtures of per- and polyfluoroalkyl substances: a systematic review of statistical methods.","volume":"205","author":"Rosato","year":"2021","journal-title":"Environ Res"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12944-025-02582-x","article-title":"Age-specific associations between per- and polyfluoroalkyl substances exposure and metabolic syndrome: a cross-sectional study.","volume":"24","author":"Lin","year":"2025","journal-title":"Lipids Health Dis"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine.","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N Engl J Med"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"131337","DOI":"10.1016\/j.neucom.2025.131337","article-title":"A comprehensive benchmark of machine and deep learning models on structured data for regression and classification.","volume":"655","author":"Shmuel","year":"2025","journal-title":"Neurocomputing"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics.","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies.","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","article-title":"Explainable machine-learning predictions for the prevention of hypoxaemia during surgery.","volume":"2","author":"Lundberg","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"e70056","DOI":"10.1111\/cts.70056","article-title":"Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development.","volume":"17","author":"Ponce-Bobadilla","year":"2024","journal-title":"Clin Transl Sci"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1007\/s10462-022-10304-3","article-title":"Explainable AI for clinical and remote health applications: a survey on tabular and time series data.","volume":"56","author":"Di Martino","year":"2022","journal-title":"Artif Intell Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:00:33Z","timestamp":1785945633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":36,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048599","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2026-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}